Eli Lilly & Co (LLY): Shareholders' Equity
$26.54B
As of 2025-12-31
$33.88B
As of 2026-06-30
+35.6%
3-year compound annual growth
+36.3%
5-year compound annual growth
+6.2%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $26.54B | +85.9% | 2026-02-12, Balance as of period end |
| 2024-12-31 | $14.27B | +32.5% | 2026-02-12, Balance as of period end |
| 2023-12-31 | $10.77B | +1.1% | 2025-02-19, Balance as of period end |
| 2022-12-31 | $10.65B | +18.6% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $8.98B | +59.2% | 2023-02-22, Balance as of period end |
| 2020-12-31 | $5.64B | +116.4% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $2.61B | -73.5% | 2021-02-17, Balance as of period end |
| 2018-12-31 | $9.83B | -15.2% | 2020-02-19, Balance as of period end |
| 2017-12-31 | $11.59B | -17.2% | 2019-02-19, Balance as of period end |
| 2016-12-31 | $14.01B | -3.9% | 2018-02-20, Balance as of period end |
| 2015-12-31 | $14.57B | -5.2% | 2018-02-20, Balance as of period end |
| 2014-12-31 | $15.37B | -12.8% | 2017-02-21, Balance as of period end |
| 2013-12-31 | $17.63B | +19.4% | 2016-02-19, Balance as of period end |
| 2012-12-31 | $14.77B | +9.0% | 2015-02-19, Balance as of period end |
| 2011-12-31 | $13.54B | n/a | 2014-02-19, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Eli Lilly & Co (LLY) | 2025-12-31 | $26.54B | +85.9% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $52.66B | +13.6% |
| Pfizer Inc (PFE) | 2025-12-31 | $86.78B | -1.9% |
| AbbVie Inc. (ABBV) | 2025-12-31 | -$3.27B | n/m |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $18.47B | +13.1% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $81.54B | +14.1% |
| Abbott Laboratories (ABT) | 2025-12-31 | $52.13B | +9.4% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $7.91B | +47.1% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $31.26B | +6.5% |
Compare LLY, MRK, PFE, ABBV side by side · Screen every company in Pharmaceutical Preparations ↗